Donald Morin is VP of Sales and Clinical Management at Medical Research Networx Diagnostics. Mr. Morin joined IMPATH/BCP In 2000 where he helped design and manage clinical studies and biospecimen procurement. In 2003 Mr. Morin started a new venture, Bay State Biologicals (BSB) specializing in providing biospecimens from patients with Cardiovascular disorders, Infectious Disease, Cancers, etc. to the biotechnology community. BSB successfully supported in vitro diagnostic regulatory submissions across multiple disease areas for both manual and automated diagnostic assay formats. Mr. Morin has successfully managed clinical study designs, operations, and patient enrolments for MRNDx since 2011.